Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127404322 | 12740432 | 2 | F | 20160810 | 20160921 | 20160913 | 20160929 | EXP | US-TEVA-690344USA | TEVA | 77.44 | YR | M | Y | 0.00000 | 20160929 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127404322 | 12740432 | 1 | PS | ATENOLOL. | ATENOLOL | 1 | Unknown | U | 74056 | 100 | MG | ||||||||
| 127404322 | 12740432 | 2 | SS | ATENOLOL. | ATENOLOL | 1 | Unknown | U | 74056 | 50 | MG | ||||||||
| 127404322 | 12740432 | 3 | SS | XTANDI | ENZALUTAMIDE | 1 | Oral | 160 MILLIGRAM DAILY; | Y | 0 | 160 | MG | QD | ||||||
| 127404322 | 12740432 | 4 | SS | XTANDI | ENZALUTAMIDE | 1 | Oral | 160 MILLIGRAM DAILY; | Y | 0 | 160 | MG | QD | ||||||
| 127404322 | 12740432 | 5 | C | WELCHOL | COLESEVELAM HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127404322 | 12740432 | 6 | C | DIGOXIN. | DIGOXIN | 1 | 0 | ||||||||||||
| 127404322 | 12740432 | 7 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 127404322 | 12740432 | 8 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127404322 | 12740432 | 9 | C | GLIPIZIDE. | GLIPIZIDE | 1 | 0 | ||||||||||||
| 127404322 | 12740432 | 10 | C | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127404322 | 12740432 | 11 | C | COMTAN | ENTACAPONE | 1 | 0 | ||||||||||||
| 127404322 | 12740432 | 12 | C | LUPRON DEPOT | LEUPROLIDE ACETATE | 1 | 0 | ||||||||||||
| 127404322 | 12740432 | 13 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127404322 | 12740432 | 14 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127404322 | 12740432 | 1 | Product used for unknown indication |
| 127404322 | 12740432 | 3 | Prostate cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127404322 | 12740432 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127404322 | 12740432 | Fall | |
| 127404322 | 12740432 | Laceration | |
| 127404322 | 12740432 | Localised infection | |
| 127404322 | 12740432 | Muscular weakness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127404322 | 12740432 | 3 | 20160617 | 20160810 | 0 | |
| 127404322 | 12740432 | 4 | 20160815 | 0 |